FDA Inspection 885332 — Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Limited — FEI 3004672766

The FDA completed an inspection of Glenmark Pharmaceuticals Limited on May 30, 2014 in Colvale. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
May 30, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Colvale (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.